PDG14 COST-UTILITY OF DALBAVANCIN VERSUS STANDARD OF CARE (SOC) IN PATIENTS WITH ABSSSI IN ITALY.

Saved in:
Bibliographic Details
Title: PDG14 COST-UTILITY OF DALBAVANCIN VERSUS STANDARD OF CARE (SOC) IN PATIENTS WITH ABSSSI IN ITALY.
Authors: Rotundo, M.1 (AUTHOR), Bini, C.2 (AUTHOR), Marcellusi, A.3 (AUTHOR), Mennini, F.S.3 (AUTHOR)
Source: Value in Health. 2019 Supplement 3, Vol. 22, pS599-S599. 1p.
Database: Academic Search Ultimate
Description
ISSN:10983015
DOI:10.1016/j.jval.2019.09.1028